SVWAG
KRYS icon

Sound View Wealth Advisors Group’s Krystal Biotech KRYS Stock Holding History

Sound View Wealth Advisors Group’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$565K Sell
1,519
-75
-5% -$22.4K 0.04% 265
2026
Q1 		$412K Buy
1,594
+15
+0.9% +$3.99K 0.03% 299
2025
Q4 		$389K Sell
1,579
-424
-21% -$89.2K 0.03% 312
2025
Q3 		$354K Buy
2,003
+56
+3% +$8.38K 0.02% 327
2025
Q2 		$268K Buy
1,947
+432
+29% +$63.5K 0.02% 363
2025
Q1 		$273K Buy
1,515
+95
+7% +$16K 0.02% 350
2024
Q4 		$222K Buy
1,420
+220
+18% +$39K 0.02% 382
2024
Q3 		$218K Buy
+1,200
New +$231K 0.02% 388

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sound View Wealth Advisors Group's KRYS Position: Q2 2026 in Review

Sound View Wealth Advisors Group reduced its Krystal Biotech (KRYS) stake by 4.7% in Q2 2026, selling an estimated $22.4K and leaving 1,519 shares worth $565K. The position accounts for 0.04% of the portfolio, ranked #265.

Sound View Wealth Advisors Group first reported a position in KRYS in Q3 2024 and has held it in 8 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Sound View Wealth Advisors Group held 1,519 shares of Krystal Biotech worth $565K as of Q2 2026.
  • Sound View Wealth Advisors Group sold 75 Krystal Biotech shares in Q2 2026, an estimated $22.4K.
  • Krystal Biotech made up 0.04% of Sound View Wealth Advisors Group's portfolio in Q2 2026, its #265 holding.
  • Sound View Wealth Advisors Group first reported a position in Krystal Biotech in Q3 2024 and has held it in 8 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Sound View Wealth Advisors Group's 13F filing for Q2 2026, filed 11 Aug 2026.